Physician profile
Linda Hendricks
NPI 1881639821
$8,555.50
in general payments reported to CMS, 2019-2025
66 companies · $1,370 in 2025
The $1,370 reported for 2025 was more than what 91% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,254 · 2020: $644 · 2021: $1,099 · 2022: $1,455 · 2023: $1,861 · 2024: $872 · 2025: $1,370.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,081 · Education: $22.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,080.60 |
| Education | $22.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $638.32 | 2019-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Amgen INC. | $484.35 | 2019-2023 | Kyprolis, Lumakras, Blincyto |
| Novartis Pharmaceuticals Corporation | $460.40 | 2019-2025 | |
| Pfizer INC. | $411.92 | 2019-2025 | |
| Janssen Biotech, INC. | $392.93 | 2019-2025 | Tecvayli, Darzalex, Talvey |
| Abbvie INC. | $381.27 | 2020-2025 | |
| Astellas Pharma US INC | $343.52 | 2019-2025 | Xtandi, Padcev, Xospata |
| Pharmacyclics LLC, An Abbvie Company | $328.02 | 2019-2023 | Imbruvica |
| Gilead Sciences, INC. | $311.27 | 2019-2025 | Trodelvy |
| Stemline Therapeutics INC. | $291.77 | 2023-2025 | Orserdu, Elzonris |
| Takeda Pharmaceuticals U.S.A., INC. | $284.87 | 2019-2025 | Ninlaro, Alunbrig, Iclusig |
| Genentech USA, INC. | $282.50 | 2019-2025 | Polivy, Lunsumio, Gazyva |
| Global Blood Therapeutics, INC. | $261.56 | 2021-2022 | |
| Seagen INC. | $258.06 | 2019-2023 | Padcev |
| Glaxosmithkline, LLC. | $222.07 | 2020-2025 | Ojjaara, Zejula, Jemperli |
Show all 66 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exelixis INC. | $205.10 | 2020-2025 | Cabometyx |
| Beigene USA, INC. | $201.31 | 2022-2025 | Brukinsa |
| Incyte Corporation | $191.83 | 2020-2025 | Jakafi, Zynyz, Monjuvi |
| Genzyme Corporation | $190.78 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $178.27 | 2023-2025 | Libtayo |
| Astrazeneca Pharmaceuticals LP | $175.05 | 2019-2023 | Lynparza |
| Array Biopharma INC | $171.42 | 2020-2025 | Braftovi, Mektovi, Lorbrena |
| Celgene Corporation | $169.29 | 2019-2023 | Opdualag, Reblozyl |
| Clovis Oncology, INC. | $115.37 | 2019 | |
| Kite Pharma, INC. | $109.49 | 2020-2023 | Yescarta |
| Eisai INC. | $105.03 | 2019-2024 | |
| Lilly USA, LLC | $97.50 | 2020-2025 | Jaypirca, Verzenio |
| Ipsen Biopharmaceuticals, INC | $82.37 | 2019-2025 | Onivyde |
| Immunogen, INC. | $79.94 | 2023-2024 | Elahere, Elahere |
| E.R. Squibb & Sons, L.L.C. | $69.95 | 2019-2023 | Opdivo, Opdualag |
| Aveo Pharmaceuticals, INC. | $68.24 | 2023-2025 | Fotivda |
| Mirati Therapeutics, INC. | $64.74 | 2023-2024 | Krazati |
| Daiichi Sankyo INC. | $63.16 | 2021-2023 | Injectafer |
| Medtronic, INC. | $57.16 | 2024-2025 | Osteocool Rf Ablation System |
| Azurity Pharmaceuticals, INC. | $50.54 | 2025 | Vivimusta, Danziten |
| Karyopharm Therapeutics INC. | $49.92 | 2022-2023 | Xpovio |
| Sun Pharmaceutical Industries INC. | $45.33 | 2022-2024 | |
| Cti Biopharma Corp. | $39.32 | 2023 | Vonjo |
| Morphosys, US INC. | $34.54 | 2022-2024 | Monjuvi |
| Puma Biotechnology, INC. | $34.50 | 2023-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $33.29 | 2022-2024 | |
| Adc Therapeutics America, INC. | $32.24 | 2022 | |
| Mylan Institutional INC. | $31.08 | 2021-2023 | Ogivri |
| Secura Bio, INC. | $30.65 | 2022 | |
| Deciphera Pharmaceuticals INC. | $29.52 | 2021-2022 | |
| Coherus Oncology, INC. | $28.37 | 2021-2023 | |
| Sobi, INC | $27.30 | 2025 | |
| Adaptive Biotechnologies Corporation | $26.93 | 2024 | Clonoseq |
| Pharmacosmos Therapeutics INC. | $24.65 | 2024 | Cosela |
| Rigel Pharmaceuticals, INC. | $23.07 | 2025 | Gavreto, Rezlidhia, Tavalisse |
| Beone Medicines USA, INC. | $22.41 | 2025 | Brukinsa |
| Janssen Pharmaceuticals, INC | $22.00 | 2024 | Rybrevant |
| Lexicon Pharmaceuticals, INC. | $20.83 | 2019 | |
| Springworks Therapeutics, INC. | $20.22 | 2025 | Ogsiveo |
| Acrotech Biopharma INC. | $18.72 | 2025 | Beleodaq |
| Amag Pharmaceuticals, INC. | $17.09 | 2019 | |
| Acceleron Pharma, INC. | $16.43 | 2021 | |
| Emd Serono, INC. | $15.72 | 2021 | |
| Spectrum Pharmaceuticals INC. | $15.41 | 2025 | Rolvedon |
| Geron Corporation | $15.37 | 2025 | Rytelo |
| Tesaro, INC. | $14.87 | 2019 | |
| Hologic Sales and Service, LLC | $13.77 | 2023 | Trident Specimen Radiography System |
| Medtronic USA, INC. | $13.47 | 2019 | |
| Organon LLC | $13.27 | 2025 | Ontruzant |
| Alexion Pharmaceuticals, INC. | $13.14 | 2021 | |
| Blueprint Medicines Corporation | $12.70 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Linda Hendricks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.